Economic Evaluation of Evusheld for Preexposure Prevention of COVID-19 in High-Risk Populations: Early Evidence from Thailand.

Waranya RattanavipapongChittawan PoonsiriWanrudee IsaranuwatchaiSopon IamsirithawornJutarat ApakupakulChaninan SonthichaiRungrueng KitphatiYot Teerawattananon

Published in: Applied health economics and health policy (2023)

Among three COVID-19-vaccinated immunocompromised patient populations, this study concluded that Evusheld was cost-effective for dialysis patients with inadequate immune response to the COVID-19 vaccine.

Keyphrases

coronavirus disease
sars cov
respiratory syndrome coronavirus
case report
men who have sex with men
intensive care unit